Use of drug-eluting stents in patients with coronary artery disease and renal insufficiency. - Wikidata - wikimedia - TriplyDB

Use of drug-eluting stents in patients with coronary artery disease and renal insufficiency.

Use of drug-eluting stents in patients with coronary artery disease and renal insufficiency.

http://www.wikidata.org/entity/Q37684624

about

The management of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery.Coronary Revascularization in Patients with CKD Stage 5D: Pragmatic Considerations.Dual Antiplatelet Therapy and Clinical Outcomes after Coronary Drug-Eluting Stent Implantation in Patients on Hemodialysis.Prevalence and impact of cardiovascular risk factors among patients presenting with acute coronary syndrome in the middle East.Long-Term Percutaneous Coronary Intervention Outcomes of Patients with Chronic Kidney Disease in the Era of Second-Generation Drug-Eluting Stents.Cardiovascular risk factors profile in patients with acute coronary syndrome with particular reference to left ventricular ejection fraction.Cardiovascular Outcomes in Patients on Hemodialysis following Drug-Eluting versus Bare-Metal Coronary Stents.

P2860

Q37808050-7D85224D-3D4E-416B-9959-B61B3FAF5293 Q38834281-B81F5C43-8A68-4E4C-8D79-88A2A625CEA9 Q38973363-683CA21A-ACA7-48EC-BE4F-2EF50173902E Q43522329-B45F8E5A-ECBE-4E8E-9788-B2BBD40FDD7C Q49639946-476823AA-524C-4A48-AA8E-FD101E926084 Q49887603-89F857A7-70D3-4791-928F-522AD336D202 Q55260543-5F22BAAB-E0A2-4485-8BA7-CDA1D36042DF

P2860

Use of drug-eluting stents in patients with coronary artery disease and renal insufficiency.

http://www.wikidata.org/entity/Q37684624

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Use of drug-eluting stents in ...... sease and renal insufficiency.

@en

Use of drug-eluting stents in ...... sease and renal insufficiency.

@nl

type

label

Use of drug-eluting stents in ...... sease and renal insufficiency.

@en

Use of drug-eluting stents in ...... sease and renal insufficiency.

@nl

prefLabel

Use of drug-eluting stents in ...... sease and renal insufficiency.

@en

Use of drug-eluting stents in ...... sease and renal insufficiency.

@nl

P1433

Q37684624-7C20689C-4C36-4FF1-A034-EC406FC39374

P1476

Q37684624-D9DD96AA-07BA-4DFC-A253-236FFC68808F

P2093

Q37684624-140C608D-B020-42B3-B17F-E87F1A8CE304

Q37684624-18756FDF-ABCA-4331-A1A8-8232E2122AFB

Q37684624-403C5A3A-1516-4BB3-BD67-0D9A15D06B9D

P2860

Q37684624-0FB074F8-39CD-4323-8094-1004E9C7C443

Q37684624-10B81ABA-E154-4C48-851B-FC8336C82B09

Q37684624-17DD3B8F-B58C-4E6D-97CD-60D9D48352E1

Q37684624-18A3196C-66A2-4DFB-A29D-792E77A17A1A

Q37684624-1E32EAA3-6E1C-4368-9676-6C5006276B02

Q37684624-25C79FF0-D15E-4372-925B-CFDE94FAF677

Q37684624-2B8498F6-5734-4B26-844B-07D35B2A6910

Q37684624-368681A3-E43D-4DD7-A91F-514F517A357E

Q37684624-39161914-A939-429B-AD9B-AEE3D8DA699D

Q37684624-3A807E8E-35A6-41E1-9CD0-43AC0AA774B9

P304

Q37684624-484F1832-AA8D-4CD7-867D-2BEDFBA2E923

P31

Q37684624-F6C884A7-2CE9-40ED-B41F-FAB8873BC174

Q37684624-f9343777-4f3f-4d80-acf0-1d913caa90b1

P356

Q37684624-C00AB01F-F3EB-4549-ADEE-31A3E0D80E5B

P407

Q37684624-288084D6-B3A2-431F-BB1B-9F43ABF2AF39

P433

Q37684624-4C1422F0-6960-448D-8DFC-06D769C5DA78

P478

Q37684624-FBA6737E-8DE4-4E25-99C1-D3F02341E424

P577

Q37684624-987F6AD0-3A27-4E1F-8D63-B3ECE2767E83

P5875

Q37684624-C5CD588C-73B1-41BC-8169-F01EB4C1924F

P698

Q37684624-83BAFC59-E9FD-4F9A-9F65-B9064EE1465A

P932

Q37684624-D30A5FEE-C236-49E0-AFFF-CC1429DDE5E7

P356

P1433

Mayo Clinic Proceedings

P1476

Use of drug-eluting stents in ...... sease and renal insufficiency.

@en

P2093

Ayman A El-Menyar

http://www.w3.org/2001/XMLSchema#string

David R Holmes

http://www.w3.org/2001/XMLSchema#string

Jassim Al Suwaidi

http://www.w3.org/2001/XMLSchema#string

P2860

Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

Acute myocardial infarction and renal dysfunction: a high-risk combination

Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery

Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment

Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.

The renal patient with coronary artery disease: current concepts and dilemmas.

Percutaneous coronary intervention in patients with end-stage renal disease.

P304

165-171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4065/MCP.2009.0314

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41191448

http://www.w3.org/2001/XMLSchema#string

P698

20118392

http://www.w3.org/2001/XMLSchema#string

P932

2813825

http://www.w3.org/2001/XMLSchema#string